APA (7th ed.) Citation

N, H., H, T., N, I., N, A., S, Y., GM, O., . . . T, U. (2025). Epigenetic disruption of adipogenic gene enhancers in dedifferentiated liposarcomas and its therapeutic value. Frontiers in oncology, 15, 1419877. https://doi.org/10.3389/fonc.2025.1419877

Chicago Style (17th ed.) Citation

N, Hattori, et al. "Epigenetic Disruption of Adipogenic Gene Enhancers in Dedifferentiated Liposarcomas and Its Therapeutic Value." Frontiers in Oncology 15 (2025): 1419877. https://doi.org/10.3389/fonc.2025.1419877.

MLA (9th ed.) Citation

N, Hattori, et al. "Epigenetic Disruption of Adipogenic Gene Enhancers in Dedifferentiated Liposarcomas and Its Therapeutic Value." Frontiers in Oncology, vol. 15, 2025, p. 1419877, https://doi.org/10.3389/fonc.2025.1419877.